SYDNEY KARP: Open Payments
NPI 1144749334 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,918 in 302 payments from 20 companies in 2025. Trend: 2023 $6,385 · 2024 $4,719 · 2025 $5,918
Food & beverage: $5,587Consulting: $250Education: $82
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $764 |
| ABBVIE INC. | 42 | $655 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 30 | $630 |
| LEO Pharma Inc. | 23 | $500 |
| Amgen Inc. | 17 | $449 |
| Incyte Corporation | 25 | $406 |
| UCB, Inc. | 20 | $402 |
| GENZYME CORPORATION | 15 | $364 |
| Lilly USA, LLC | 22 | $330 |
| Organon LLC | 10 | $311 |
Products named: TREMFYA, Winlevi, OTEZLA, OPZELURA, Bimzelx, DUPIXENT, RINVOQ, VTAMA.
Industry payments across NY — which companies pay providers there.
